8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 30, 2019

Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-35141	68-0370244
(Commission File Number)	(I.R.S. Employer Identification No.)

400 S. Australian Avenue, Suite 800, West Palm Beach, Florida	33401
(Address of Principal Executive Offices)	(Zip Code)

(561) 855-1626

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 7.01. Regulation FD Disclosure

On October 30, 2019, Rennova Health, Inc. (the “Company”) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. A copy of the press release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.

The information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Exhibit Description
99.1	Press Release dated October 30, 2019
99.2	Transcript of Interview of Seamus Lagan

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 30, 2019	RENNOVA HEALTH, INC.
	By:	/s/ Seamus Lagan
		Seamus Lagan
		Chief Executive Officer
		(principal executive officer)

3

EX-99.1

rennova health discusses the timing of filing 2019 quarterly reports to regain compliance, with the stock day podcast

WEST PALM BEACH, Fla. (October 30, 2019) – Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its third rural hospital in Tennessee at the beginning of March 2019, announces that Rennova CEO and President of the Company, Seamus Lagan, joined Stock Day host Everett Jolly for a business update.

Jolly began the interview by noting that the Company has now filed the outstanding 2018 audited financial statement and asked when the 2019 quarterly reports will be filed. Lagan explained that the Company’s 10-Qs should be filed within the next couple of weeks, including their third 10-Q which is due by November 14th. “You do get a five-day extension, but really by mid-November I’d like to see the Company all filed, up-to-date, and with our financial information out there and available to investors,” said Lagan.

“Do you still plan to complete the 1 for 10,000 reverse split that was previously planned?”, asked Jolly. “We have no option but to complete that reverse split,” replied Lagan, adding that the reverse will result in a minimal number of shares issued and outstanding. “It should start to reflect a very different value for the company,” said Lagan.

Jolly then commented on the Company’s third acquisition, Jellico, and asked whether or not this facility has started generating cash flow. Lagan explained that it took approximately seven months for Jellico to begin collecting its revenue and confirmed that the cash is finally starting to get collected. “That is making life a lot easier for operations. It allows us to get our focus back to reopening the Jamestown hospital,” said Lagan. “It’s good to see that cash flow starting and these hospitals starting to pay their own way.”

“Do you have a date set for the reopening of the Jamestown facility?”, asked Jolly. Seamus shared that the Company does not have an official date set for the reopening of the hospital but has already begun hiring at that location. “There’s quite a lot to do, but we’re really looking forward to all three facilities operating. It’s then that we can start to get some real synergy in costs, savings, and services, and see the revenues increasing,” said Lagan.

To close the interview, Lagan shared that the past few months have presented many challenges to the Company, however they are overcoming these challenges thanks to an experienced and driven management team. “I think anyone looking at this company and this management team will have to realize that we don’t give up. So, we will get there,” said Lagan, adding that for the remainder of this year the Company will focus on the reopening of their Jamestown facility. “Once we’re compliant and do complete the reverse, I think it allows us to restructure some of the existing debt that the Company has and will put us in a much better position for next year.”

To hear Seamus Lagan’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7409415-rennova-health-inc-discusses-the-company-s-current-challenges-with-the-stock-day-podcast

About Rennova Health, Inc.

Rennova operates three rural hospitals and a physician’s office in Tennessee and a physician’s office in Kentucky and provides industry-leading diagnostics and supportive software solutions to healthcare providers. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Contacts:

Rennova Health

Sebastien Sainsbury, 561-666-9818

ssainsbury@rennovahealth.com

# # #

EX-99.2

Rennova Health Interview

CEO Seamus Lagan on Uptick Newswire October 2019

Speakers: Everett Jolly and Seamus Lagan

Jolly: On today’s show, I’m bringing you back a returning guest who was on my show back on the 1st of October of this year. We’re talking no other than Rennova Health, Inc. You can find them on the OTC markets under the ticker symbol “RNVA”, and with us today is the CEO and President of the company. He’s going to bring us up to speed. I know he’s had a lot on his plate and a lot to answer for, Seamus Lagan. Seamus, welcome back to the show. Appreciate it.

Lagan: Everett, thank you. Thanks for having me back. I appreciate the opportunity to get an update out to everybody.

Jolly: You have filed your outstanding audit financials. So, we assume that you’re going to file the outstanding 10-Qs for the first two quarters and get back to compliance. That being said, when do you believe that this will happen and when will you also be filing the last 10-Q for the third quarter before its due date in November?

Lagan: So, it took a long time to get that 10-K out; new auditors and new financial team. It was long overdue, but we’re pretty pleased to have gotten it finished up and out the door. The Q’s are going to be very quick behind that, Everett. I don’t expect them to take any longer than the next couple of weeks for both of them. We’re making every effort to actually get the third Q out - as you said the third Q is due by November 15th. We’d like to see that out the door on-time. You do get a five-day extension, but really by mid-November I’d like to see the company all filed, up-to-date, and with our financial information out there and available to investors.

Jolly: You know, there’s been a lot of talk about your reverse split. I will be blunt and just come out and ask you: Do you still plan to complete the 1 for 10,000 reverse split that was previously planned?

Lagan: We have no option but to complete that reverse split. The share price down at these levels has so many restrictions for so many people that the 1 for 10,000 reverse split is going to be necessary. Obviously, we have to be compliant with the SEC filings and we need permission from FINRA to complete it. As bluntly in return: Yes, we intend to complete that reverse. The end result of that would be a pretty minimal number of shares issued and outstanding – probably less than a million shares. So, it should start to reflect a very different value on the company.

Jolly: You know, as we spoke before about the third acquisition and cash flow, it’s all about money coming in the door - that will take care of most of your problems. That being said, you previously mentioned on the show about the third acquisition, Jellico, which was starting to create cash flow. Has that happened, what can we expect from the cash flow position, and where are we at?

Lagan: It did happen. It was a slow start, and like everything else, a dollar short and a day late compared to what we might always like. But it has started to collect. The billing team, their functioning took a long time to get to there, as I previously said, about six to seven months. You know, that is making life a lot easier for operations. It allows us to get our focus back now to reopening the Jamestown hospital. So, it’s good to be here. It’s good to see that cash flow starting and these hospitals starting to pay their own way.

Page 1

Jolly: Well, I’m glad you brought up the Jamestown hospital. Do you have a date set for the reopening of that facility?

Lagan: Everett, we don’t have a date set. We have just in the last week to two weeks started to rehire. We have a couple of adverts out in the local community - hopefully that will attract some of the previous staff back. The first position is an HR generalist to help with the rest of the team. So, the CEO down there, Michael Alexander, is working with the regulatory authorities and we continue to communicate with them. We don’t have a date, but hopefully not in the too distant future and we very definitely are hoping that it’s open well before the end of the year. I don’t want to commit to November, but if we can make it happen before we’re out of November, we will. That’s probably ambitious because we have people to hire. There’s quite a lot to do, but we’re really looking forward to all three facilities operating and I think it’s then that we can start to get some real synergy in costs and savings and services, and see the revenues increasing.

Jolly: If you could share some words of wisdom to your stockholders, especially to my audience, what would be your closing statements through this, I wouldn’t say debacle, but definitely some rough times you guys have been going through in the last sixty to ninety days?

Lagan: Well, I’ll not agree with the word “debacle” but this year has certainly been a rollercoaster that had its turmoil. I’d say we’ve weathered the most of it. We still have to keep our heads down and keep pushing forward, and we continue to do that. I think anyone looking at this company and looking at this management team will have to realize that we don’t give up. So, we will get there. The remainder of the year really has a focus on trying to get that Jamestown hospital reopened and having all of the hospitals functioning as we expect them to. Once we’re compliant and do complete the reverse, I think it allows us to restructure some of the existing debt that the company has and will put us in a much better position for next year.

Jolly: Seamus, I want to thank you for stopping by. I always love it when you come on this show. I’m still a believer in what you guys are doing out there. I know you’re going to turn it around. You are determined to make things happen. From the get-go, you’ve been on my show for the last couple of years, you said you were going to do x, y, and z, and you’ve done x, y, and z, and if it was easy everybody would be a CEO of a publicly-traded company. So, I want to thank you for coming on the show.

Lagan: Everett, I appreciate you having me. There certainly are days when I’d be happy to let someone sit in my seat, but regardless we’ll get there. I do believe, I’ve said this before, that we’ve overseen a transition from a heavy focus in diagnostics, actually the core business was diagnostics, to a rural hospital model, and I’m very confident that we will make this model work and work very well going forward.

Jolly: Thank you so much, and I will talk to you soon.

Lagan: Thanks Everett.

Page 2